We provide targeted DNA sequencing allowing us to focus specific areas of interest at a reduced price and faster delivery time. Our laboratory’s technology can accommodate small blood sample sizes, making it viable alternative to a trip to the phlebotomist and reducing the impact of blood-drawing on patients’ health.
NEXT GENERATION SEQUENCING – GERMLINE MUTATION
Our Cardio Sequencing Panel targets 174 genes with known associations to 17 inherited cardiac conditions including cardiomyopathy, arrhythmia, hypercholesterolemia, hypertriglyceridemia, aortopathy and more. This assay is performed using genomic DNA isolated from human peripheral whole blood specimens.
The test is intended to identify the variants that are associated with cardiac conditions. It is performed as a pre-symptomatic genetic test in order to determine whether persons with a family history of a cardiac disease, but no current symptoms, have alterations associated with the disease. The test can also be used for post-symptomatic genetic testing to confirm variants of association to cardiac disease.
All tests are performed in Ayass BioScience, LLC. Ayass BioScience, LLC (DBA Ayass Lung Clinic, PLLC) is a CLIA certified laboratory. If you have any questions about Genetic Testing Next Generation Sequencing at Ayass BioScience, LLC, please call today at 972-668-6005 or fill out our contact form on the bottom of this page. We will answer any question you might have.
No announcement available or all announcement expired.